Business Information

• Voithru Wraps Up 2nd t ōtus Translation Contest with Great Success

  

  Record-Breaking 3,586 Translators Participated in tōtus Translation Contest SEOUL,South Korea,Feb. 17,2025-- On February 8,2025,VOITHRU,a leader in cultural content translation,successfully concluded

  02-18

  Details

• Minish Holds First Seminar in Japan with Great Success - Over 100 Dentists in Attendance

  

  "Impressed by Extensive Full-Mouth Rehabilitation Cases","Anti-Aging Effects Highly Praised"

  02-18

  Details

• Reolink Makes Wireless Security Camera Systems Accessible to All Homes

  

  LOS ANGELES,Feb. 17,2025-- Every homeowner deserves peace of mind when it comes to home security. Reolink,an innovative leader in intelligent visual technology for the home,brings the Wireless Securi

  02-18

  Details

• Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

  

  The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration

  02-17

  Details

• ATxEnterprise 2025 Celebrates Five Years of Powering Enterprise Technology, Cybersecurity, and Digital Transformation

  

  SINGAPORE,Feb. 14,2025-- ATxEnterprise (ATxE) 2025,a flagship event of Asia Tech x Singapore (ATxSG),returns for its fifth year,providing a strategic platform for enterprises,governments,and technolo

  02-17

  Details

• NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPO

  

  NEW YORK,Feb. 14,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

  02-17

  Details

• Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

  

  SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

  02-14

  Details

• DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

  

  SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

  02-14

  Details

• Year of the Snake Celebrations Bring Lively Festivities to Cangzhou

  

  CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi

  02-14

  Details

• AI is turbocharging media production and democratizing creativity, but challenges persist for the industry, reveals new MIT Technology Review Insights research report

  

  Digital media standards underlie every advance CAMBRIDGE,Mass.,Feb. 13,2025-- A new report byMIT Technology Review Insights explores how emerging tech is remaking the media and entertainment industri

  02-14

  Details